webinar register page

Planning for CGT commercialization: It starts sooner than you think
Every decision throughout cell and gene therapy preclinical development is an opportunity to set the stage for future commercial success. From anticipating supply needs to planning ahead for commercial scale-up, what are the major factors that influence commercial readiness for these therapies at every stage?

THIS ENDPOINTS STUDIO-ASSEMBLED PANEL WILL EXPLORE:

- Practical strategies to create a seamless, adaptive manufacturing plan from preclinical development to commercialization
- How integrated scale-down platforms can inform future scale-up decisions
- Where the industry is headed next with data analytics, automation and technology

00:46:00

* Required information
Loading